Pliant Therapeutics, Inc.

NASDAQ:PLRX

1.52 (USD) • At close March 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20242023202220212020201920182017
Revenue 01.589.6857.57241.81757.05200
Cost of Revenue 003.6813.204000.6660
Gross Profit 01.586.0044.36841.81757.052-0.6660
Gross Profit Ratio 010.620.5771100
Reseach & Development Expenses 169.31127.79796.93677.54966.19347.35324.41514.526
General & Administrative Expenses 59.05557.92839.94927.55817.26910.936.53.823
Selling & Marketing Expenses 00000000
SG&A 59.05557.92839.94927.55817.26910.936.53.823
Other Expenses 000-77.549-0.366-0.216-0.0490
Operating Expenses 228.365185.725136.88527.55883.46258.28330.91518.349
Operating Income -228.365-184.145-127.2-19.986-41.645-1.231-30.915-18.349
Operating Income Ratio 0-116.547-13.134-2.639-0.996-0.02200
Total Other Income Expenses Net 18.06122.8093.8790.2720.1120.60.6390.016
Income Before Tax -210.304-161.336-123.321-19.714-41.533-0.631-30.276-18.333
Income Before Tax Ratio 0-102.111-12.733-2.604-0.993-0.01100
Income Tax Expense 00-1.823-1.807-1.788-0.8160.6392.289
Net Income -210.304-161.336-121.498-17.907-39.7450.185-30.276-20.622
Net Income Ratio 0-102.111-12.545-2.365-0.950.00300
EPS -3.47-2.75-2.89-0.5-1.120.005-1.83-25.67
EPS Diluted -3.47-2.75-2.89-0.5-1.120.005-1.83-25.67
EBITDA -228.365-158.228-118.849-95.728-40.335-0.118-30.249-18.057
EBITDA Ratio 0-100.144-12.652-2.639-0.996-0.00200